AGP Picks
View all

New Jersey Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.

Press releases published on June 1, 2026

DR. BARBARA ETHERIDGE HONORED BY RUTGERS ODASIS FOR YEARS OF OUTSTANDING STUDENT MENTORSHIP AND SERVICE
The Cannata Report 41st Annual Awards & Charities Gala to Benefit Precision Medicine for Combat Veterans Initiative
Zealand Pharma - Transactions related to share buy-back program (week 22, 2026)
Ignoring Symptoms Can Be Costly—Check In, Not Out This Men’s Health Month
American Bakers Association Launches “Baking Feeds America” Campaign, Celebrating the Industry’s Vital Role in Nourishing the Nation
Fountain House’s “Sharing the WELLth” Speaker Series Draws Standing-Room-Only Crowds for Candid Conversations on Mental Health and Recovery
Zorronet Brings Autonomous C5ISR to Hardened Sites Without Public Cloud Dependence
Introducing Evosep Proteomics to Standardize and Scale Proteomics for Research and Drug Development
Ardena appoints Ariane de Ganck as Chief Scientific Officer
Mapi Pharma to Participate in the ASCO Annual Meeting and ADA 2026 Scientific Sessions
Inspire Launches GLP-1 Connect: A Free Community for Real Conversations About GLP-1 Therapies
ALS Canada rallies around progress in research and a call for continued action this ALS Awareness Month
La Société canadienne de la SLA met en avant les avancées de la recherche et appelle à poursuivre la lutte pendant ce mois de la sensibilisation à la SLA
Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches
Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT® Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting
MDA Expands 2026 Engage Symposium Series, Bringing the Neuromuscular Community Together in Four U.S. Cities
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones
LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors
Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Share this page:

Sign up for:

New Jersey Health Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.